In a previous study, injection of botulinum toxin A was shown to reduce the expression of VEGF in the bladder tissue of patients with IC/BPS; this was associated with a concomitant decrease in inflammatory marker levels in bladder27. The gene discussed is VEGFA; the disease is Bartsocas-Papas syndrome 1.